Exploring the Future of Regulatory Affairs Insights from Veeva R&D Summit 2023

Venturing through the Veeva Summit, I naturally focused my attention on the Regulatory Affairs track and found myself surrounded by discussions on the future of regulatory affairs. Topics ranged from Health Authority (HA) queries to Publishing, eCTD 4.0, global-to-local dossier management, and active dossier management. Most notably, Publishing emerged as a shining star, showcasing Veeva's commitment to innovation.

These discussions reflected a broader recalibration of priorities within Regulatory Affairs. Rather than treating publishing, dossier management, and HA interactions as discrete functions, many organizations are now approaching them as interconnected components of a single regulatory ecosystem.

From a veeva R&D perspective, this shift places greater emphasis on data consistency, reuse, and traceability across submissions and markets. Regulatory teams are increasingly expected to manage content with the same rigor as data, ensuring alignment across regions while remaining flexible to local requirements.

The regulatory insights shared during these sessions also underscored the growing importance of upstream readiness. Decisions made during clinical development, labeling strategy, and CMC planning now have a direct downstream impact on submission quality and timelines. As a result, regulatory functions are becoming more embedded earlier in the product lifecycle, moving from execution-focused roles to strategic contributors.

In a mere six months, the Veeva Publishing module processed a staggering 70,000 submissions, producing an impressive 4,800 files, 2.7 million hyperlinks, and 1.85 million bookmarks. For regulatory professionals, these developments signify the need to embrace innovation fully, remaining vigilant in staying updated with the latest technologies and tools within the regulatory affairs landscape. Embracing innovation isn't just an option; it's a pathway to enhanced efficiency, precision, and effectiveness in overseeing regulatory processes.

Beyond the scale itself, these volumes signal an important inflection point for regulatory operations. As submission activity increases globally, manual processes and fragmented workflows become increasingly difficult to sustain. The emphasis is shifting toward platforms that can support repeatability, consistency, and quality at scale.

From a veeva regulatory information management standpoint, publishing is no longer just a downstream task, it becomes a validation point for the integrity of the entire regulatory dataset. Errors, misalignments, or late changes upstream are amplified during submission preparation, reinforcing the need for tighter integration across regulatory activities.

For regulatory leaders, this raises practical questions around standardization, governance, and long-term scalability. Technology can enable efficiency, but only when paired with clear ownership models and disciplined operating practices. The conversations at the summit reflected this balance clearly: innovation must be accompanied by organizational readiness to realize its full value.

At the heart of the Veeva Summit was the realization that the future of regulatory affairs lies in data-driven insights. The event showcased Veeva's commitment to this vision through innovation workshops, discussions on eCTD 4.0, IDMP, PQ CMC, and other data-centric demands. The additional experiences Indegene has had in areas such as ePI, CMC, labeling, and others through Vulcan Gravitate, Accumulus, and other industry bodies are all complementary to Veeva's discussion and will further advance the data-centric focus in Regulatory leading into 2024. With experienced partners demonstrating the platform and offering support, Veeva is well-prepared to lead the way in delivering data-centric solutions to the industry.

Taken together, the discussions at the veeva R&D summit illustrate a clear trajectory for Regulatory Affairs. The function is moving toward greater integration, data reliance, and cross-functional collaboration, supported by platforms like veeva regulatory information management and emerging AI capabilities.

What becomes evident is that technology alone does not define progress. Regulatory maturity increasingly depends on how well organizations align systems, processes, and people around shared objectives. Regulatory insights drawn from the summit highlight that leaders who focus on operating models, governance, and capability development are better positioned to adapt to ongoing change.

As regulatory expectations continue to evolve, the ability to translate data into actionable insights will become a defining differentiator. The summit reinforced that this transformation is already underway, and that thoughtful, staged adoption will be key to sustaining long-term impact.

It was an impressive three days at the Veeva Summit. Veeva's Regulatory Information Management platform has gained extensive adoption and continues to evolve, with a strong focus on compliance, productivity, and user experience. While challenges persist in areas like submission-level planning and regulatory intelligence, Veeva's commitment to innovation and partnership, particularly in Generative AI, provides a promising outlook for the future of regulatory affairs. While we eagerly await next year's Veeva summit, feel free to contact me for in-depth discussions on Generative AI, Structured Content Automation, Submissions Planning, Regulatory Intelligence, or any other topic covered in this blog.

Explore how Pharma company achieved quality and time compliant regulatory documents.